Doane John F, Jackson Randolph T
Department of Ophthalmology, University of Kansas, Kansas City, MO, USA.
Curr Opin Ophthalmol. 2007 Jul;18(4):318-24. doi: 10.1097/ICU.0b013e3281df2d6a.
To review the development, design and clinical implications of the first US Food and Drugs Administration approved accommodative lens. To inform the reader of forthcoming accommodative intraocular lens technologies that are being clinically tested and other technologies that are under design.
We present clinical data that are currently available or pending release on accommodative intraocular lenses. As much as the results of the technology can be appreciated, the approach toward the refractive mindset of the presbyopic intraocular lens patient must be understood and mastered.
Accommodative intraocular lens design and development are at a feverish pace. The lure is the perceived holy grail for the solution of presbyopia.
回顾美国食品药品监督管理局批准的首款可调节人工晶状体的研发、设计及临床意义。向读者介绍正在进行临床试验的即将问世的可调节人工晶状体技术以及其他正在设计中的技术。
我们展示了目前可获取的或即将发布的关于可调节人工晶状体的临床数据。尽管该技术的结果值得关注，但必须理解并掌握针对老花眼人工晶状体患者屈光心态的处理方法。
可调节人工晶状体的设计和研发正处于狂热阶段。其吸引力在于被视为解决老花眼问题的圣杯。
